Tubigon, Jane A.

HRN: 26-34-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2024
AMPICILLIN 1GM (VIAL)
12/16/2024
12/23/2024
IV
2 Grams
Q6
PROM X 2 HOURS
Waiting Final Action 
12/16/2024
CEFUROXIME 500MG (TAB)
12/16/2024
12/23/2024
ORAL
500mg
BID
S/P NSD With RMLE And Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: